Grifols Debt to Equity Ratio 2012-2018 | GRFS

Current and historical debt to equity ratio values for Grifols (GRFS) over the last 10 years.
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.000B $4.878B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $52.505B 11.23
Zoetis (ZTS) United States $41.588B 32.81
Jazz Pharmaceuticals (JAZZ) Ireland $10.613B 17.85
Neurocrine Biosciences (NBIX) United States $9.279B 0.00
Nektar Therapeutics (NKTR) United States $8.207B 0.00
Sage Therapeutics (SAGE) United States $7.815B 0.00
Catalent (CTLT) United States $5.759B 26.82
Ionis Pharmaceuticals (IONS) United States $5.622B 0.00
FibroGen (FGEN) United States $5.441B 0.00
Loxo Oncology (LOXO) United States $5.376B 0.00
United Therapeutics (UTHR) United States $5.362B 9.73
Taro Pharmaceutical Industries (TARO) Israel $4.509B 18.48
Madrigal Pharmaceuticals (MDGL) United States $4.090B 0.00
Ironwood Pharmaceuticals (IRWD) United States $3.024B 0.00
Aerie Pharmaceuticals (AERI) United States $2.907B 0.00
Heron Therapeutics (HRTX) United States $2.716B 0.00
USANA Health Sciences (USNA) United States $2.658B 25.57
Portola Pharmaceuticals (PTLA) United States $2.640B 0.00
Endo (ENDP) Ireland $2.509B 3.42
Spectrum Pharmaceuticals (SPPI) United States $2.500B 0.00
Enanta Pharmaceuticals (ENTA) United States $2.420B 44.70
Xencor (XNCR) United States $2.336B 0.00
TESARO (TSRO) United States $2.246B 0.00
Zogenix (ZGNX) United States $2.085B 0.00
PTC Therapeutics (PTCT) United States $1.625B 0.00
Corcept Therapeutics (CORT) United States $1.568B 26.17
Pacira Pharmaceuticals (PCRX) United States $1.509B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.460B 0.00
TherapeuticsMD (TXMD) United States $1.432B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.398B 0.00
Impax Laboratories (AMRX) United States $1.363B 29.29
ImmunoGen (IMGN) United States $1.338B 0.00
Radius Health (RDUS) United States $1.290B 0.00
Esperion Therapeutics (ESPR) United States $1.172B 0.00
Endocyte (ECYT) United States $1.168B 0.00
TRICIDA INC (TCDA) United States $1.157B 0.00
OptiNose (OPTN) United States $1.024B 0.00
Flexion Therapeutics (FLXN) United States $1.017B 0.00
Karyopharm Therapeutics (KPTI) United States $0.933B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.797B 0.00
GlycoMimetics (GLYC) United States $0.676B 0.00
Dova Pharmaceuticals (DOVA) United States $0.669B 0.00
Collegium Pharmaceutical (COLL) United States $0.646B 0.00
TRANSLATE BIO (TBIO) United States $0.631B 0.00
Aclaris Therapeutics (ACRS) United States $0.624B 0.00
CASI Pharmaceuticals (CASI) United States $0.624B 0.00
Odonate Therapeutics (ODT) United States $0.617B 0.00
ChemoCentryx (CCXI) United States $0.612B 42.97
BioCryst Pharmaceuticals (BCRX) United States $0.611B 0.00
Akebia Therapeutics (AKBA) United States $0.586B 0.00
Siga Technologies (SIGA) United States $0.557B 0.00
Depomed (DEPO) United States $0.522B 0.00
ArQule (ARQL) United States $0.489B 0.00
Lannett Co Inc (LCI) United States $0.483B 4.44
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.482B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.469B 0.00
VERRICA PHARMA (VRCA) United States $0.459B 0.00
FORTY SEVEN INC (FTSV) United States $0.458B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.453B 0.00
Majesco Entertainment (COOL) United States $0.452B 0.00
Dermira (DERM) United States $0.429B 0.00
Concert Pharmaceuticals (CNCE) United States $0.389B 0.00
XERIS PHARMA (XERS) United States $0.386B 0.00
Mast Therapeutics (SVRA) United States $0.380B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.335B 26.18
Bellicum Pharmaceuticals (BLCM) United States $0.327B 0.00
Achaogen (AKAO) United States $0.323B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.318B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.316B 0.00
NEON THERAPEUTC (NTGN) United States $0.314B 0.00
Minerva Neurosciences (NERV) United States $0.314B 0.00
Tyme Technologies (TYME) United States $0.302B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.300B 0.00
Zafgen (ZFGN) United States $0.294B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.255B 0.00
Jounce Therapeutics (JNCE) United States $0.254B 0.00
DURECT (DRRX) United States $0.243B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.242B 0.00
Redhill Biopharma (RDHL) Israel $0.235B 0.00
Ocular Therapeutix (OCUL) United States $0.234B 0.00
Galectin Therapeutics (GALT) United States $0.226B 0.00
ProNAi Therapeutics (SRRA) Canada $0.224B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.223B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.220B 0.00
Immune Design (IMDZ) United States $0.217B 0.00
Ardelyx (ARDX) United States $0.212B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.211B 0.00
Aratana Therapeutics (PETX) United States $0.208B 0.00
IMV INC (IMV) Canada $0.202B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.200B 0.00
Melinta Therapeutics (MLNT) United States $0.193B 0.00
ContraFect (CFRX) United States $0.183B 0.00
Neos Therapeutics (NEOS) United States $0.180B 0.00
Nature's Sunshine Products (NATR) United States $0.173B 0.00
Adherex Technologies (FENC) United States $0.173B 0.00
MediWound (MDWD) Israel $0.170B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.166B 0.00
Calithera Biosciences (CALA) United States $0.163B 0.00
Aldeyra Therapeutics (ALDX) United States $0.162B 0.00
MEI Pharma (MEIP) United States $0.149B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.149B 0.00
Opexa Therapeutics (ACER) United States $0.148B 0.00
Cardiome Pharma (CORV) Canada $0.137B 0.00
Molecular Templates (MTEM) United States $0.133B 0.00
CTI BioPharma (CTIC) United States $0.131B 0.00
Forward Pharma (FWP) Denmark $0.130B 0.00
Juniper Pharmaceuticals (JNP) United States $0.127B 190.83
Adamis Pharmaceuticals (ADMP) United States $0.125B 0.00
SteadyMed (STDY) Israel $0.120B 0.00
Iterum Therapeutics (ITRM) Ireland $0.117B 0.00
Nivalis Therapeutics (ALPN) United States $0.116B 0.00
Rafael Holdings (RFL) United States $0.113B 0.00
Recro Pharma (REPH) United States $0.112B 0.00
Infinity Pharmaceuticals (INFI) United States $0.110B 0.00
Affimed (AFMD) Germany $0.109B 0.00
Otonomy (OTIC) United States $0.109B 0.00
BioLineRx (BLRX) Israel $0.097B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.096B 0.00
KalVista Pharmaceuticals (KALV) United States $0.094B 0.00
Champions Oncology (CSBR) United States $0.091B 0.00
SCYNEXIS (SCYX) United States $0.087B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.084B 0.00
Natural Alternatives (NAII) United States $0.077B 9.84
Trillium Therapeutics (TRIL) Canada $0.076B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.075B 0.00
Novan (NOVN) United States $0.073B 0.00
KemPharm (KMPH) United States $0.070B 0.00
Genocea Biosciences (GNCA) United States $0.065B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.064B 0.00
Mannatechorporated (MTEX) United States $0.055B 13.50
Capnia (SLNO) United States $0.055B 0.00
Heat Biologics (HTBX) United States $0.047B 0.00
Avenue Therapeutics (ATXI) United States $0.044B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.042B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.038B 34.17
Onconova Therapeutics (ONTX) United States $0.037B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.036B 0.00
Biomerica (BMRA) United States $0.035B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.035B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.035B 0.00
ProPhase Labs (PRPH) United States $0.034B 3.87
HANCOCK JAFFE (HJLI) United States $0.034B 0.00
Xenetic Biosciences (XBIO) United States $0.032B 0.00
IsoRay (ISR) United States $0.031B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.030B 0.00
Lipocine (LPCN) United States $0.030B 0.00
Regulus Therapeutics (RGLS) United States $0.030B 0.00
Shineco (TYHT) China $0.030B 2.53
Citius Pharmaceuticals (CTXR) United States $0.028B 0.00
NanoViricides (NNVC) United States $0.028B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.025B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.025B 0.00
Can-Fite Biopharma (CANF) Israel $0.025B 0.00
Cyanotech (CYAN) United States $0.024B 23.33
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
Aviragen Therapeutics (VXRT) United States $0.022B 0.00
Aradigm (ARDM) United States $0.022B 0.00
ESSA Pharma (EPIX) Canada $0.022B 0.00
Midatech Pharma (MTP) United Kingdom $0.021B 0.00
Egalet (EGLT) United States $0.019B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
Bio-Path Holdings (BPTH) United States $0.018B 0.00
Intellipharmaceutics (IPCI) Canada $0.018B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.015B 0.00
Pain Therapeutics (PTIE) United States $0.015B 0.00
Aralez Pharmaceuticals (ARLZ) Canada $0.015B 0.00
Skyline Medical (AIPT) United States $0.014B 0.00
India Globalization Capital (IGC) United States $0.014B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.013B 0.00
Jaguar Animal Health (JAGX) United States $0.013B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.011B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.011B 0.00
PharmAthene (ALT) United States $0.009B 0.00
Apricus Biosciences (APRI) United States $0.009B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.009B 0.00
RXi Pharmaceuticals (RXII) United States $0.008B 0.00
Biostar Pharmaceuticals (BSPM) China $0.006B 3.21
Bio Blast Pharma (ORPN) Israel $0.005B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
ELECTROCORE LLC (ECOR) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00